Ribosomal protein L32 enhances hepatocellular carcinoma progression
Abstract Purpose The underlying mechanisms of hepatocellular carcinoma (HCC) have not been fully investigated, and effective biomarkers for HCC are still needed to be explored. Therefore, our study sought to thoroughly examine the clinical significance and biological functions of the ribosomal prote...
Main Authors: | Guoxin Hou, Zhimin Lu, Jialu Jiang, Xinmei Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-05-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.5811 |
Similar Items
-
DEAH-box polypeptide 32 promotes hepatocellular carcinoma progression via activating the β-catenin pathway
by: Xiaoyun Hu, et al.
Published: (2021-01-01) -
Comprehensive Analysis of NKX3.2 in Liver Hepatocellular Carcinoma by Bigdata
by: An-Na Bae, et al.
Published: (2023-10-01) -
High USP32 expression contributes to cancer progression and is correlated with immune infiltrates in hepatocellular carcinoma
by: Mengxi Xiu, et al.
Published: (2023-11-01) -
Comprehensive analysis reveals a metabolic ten-gene signature in hepatocellular carcinoma
by: Zhipeng Zhu, et al.
Published: (2020-05-01) -
Expression levels of Cx32 and Src/FAK signaling pathway in hepatocellular carcinoma tissues and their association with prognosis of patients after hepatectomy
by: Yu Meiling, Ma Xiang, Dong Shuying, Tong Xuhui
Published: (2022-10-01)